AGMB
AgomAb Therapeutics NV American Depositary Shares
NASDAQ: AGMB · HEALTHCARE · BIOTECHNOLOGY
$10.74
+0.94% today
Updated 2026-04-29
Market cap
$528.92M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.50
Dividend yield
—
52W range
$9 – $17
Volume
0.2M
AgomAb Therapeutics NV American Depositary Shares (AGMB) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Operating cash flow | $-18.97M | $-24.59M | $-46.83M | $-51.74M |
| Capital expenditures | $0.00 | $0.00 | $675000.00 | $4000.00 |
| Depreciation | — | — | — | — |
| Stock-based comp | $2.21M | $2.16M | $1.07M | $5.36M |
| Free cash flow | $-18.97M | $-24.59M | $-47.50M | $-51.74M |
| Investing cash flow | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Share repurchases | — | — | — | — |
| Debt repayment | — | — | — | — |
| Net change in cash | — | — | — | — |